Quick Answer
QuidelOrtho Corp reported R&D Expense of $186.20 million for fiscal year 2025.
QuidelOrtho Corp R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $186.20M | -14.9% |
| 2024 | $218.70M | -10.7% |
| 2023 | $245.00M | +30.4% |
| 2022 | $187.90M | +96.3% |
| 2021 | $95.70M | +13.5% |
| 2020 | $84.30M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $41.50M | -25.8% | -9.2% |
| June 30, 2025 | $45.70M | -18.8% | -14.1% |
| March 31, 2025 | $53.20M | -10.1% | -4.8% |
| September 30, 2024 | $55.90M | -9.1% | -0.7% |
| June 30, 2024 | $56.30M | -9.8% | -4.9% |
| March 31, 2024 | $59.20M | -5.0% | -3.7% |
| September 30, 2023 | $61.50M | -6.2% | -1.4% |
| June 30, 2023 | $62.40M | +82.5% | +0.2% |
- QuidelOrtho Corp showed a decrease of -14.9% in R&D Expense compared to the prior fiscal year.
- Over the 2020–2025 period, QuidelOrtho Corp’s r&d expense has grown by 120.9% (from $84.30 million to $186.20 million).
- The most recent figure is from QuidelOrtho Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: